Allergic conjunctivitis is inflammation of the conjunctiva (the membrane covering the white part of the eye) due to allergy.Although allergens differ among patients, the most common cause is hay fever. Symptoms consist of redness (mainly due to vasodilation of the peripheral small blood vessels), edema (swelling) of the conjunctiva, itching, and increased lacrimation (production of tears). If this is combined with rhinitis, the condition is termed allergic rhinoconjunctivitis.
The symptoms are due to release of histamine and other active substances by mast cells, which stimulate dilation of blood vessels, irritate nerve endings, and increase secretion of tears.
Treatment of allergic conjunctivitis is by avoiding the allergen (e.g., avoiding grass in bloom during "hay fever season") and treatment with antihistamines, either topical (in the form of eye drops), or systemic (in the form of tablets). Antihistamines, medications that stabilize mast cells, and nonsteroidal anti-inflammatory drugs (NSAIDs) are generally safe and usually effective.
2. ALLERGIC CONJUNCTIVITIS
⢠It is the inflammation of conjunctiva due to
allergic or hypersensitivity reactions which
may be immediate(humoral) or delayed
(cellular).
4. SIMPLE ALLERGIC CONJUNCTIVITIS
⢠It is a mild, non-specific allergic conjunctivitis
characterized by itching, hyperaemia and mild
papillary response.
⢠It is an acute or subacute conjunctivalreaction
to allergens.
6. PATHOPHYSIOLOGY
⢠Pathological features of simple allergic
conjunctivitis comprise vascular, cellular and
conjunctival responses.
1.Vascular response is characterised by
sudden and extreme vasodilation and
increased permeability of vessels leading to
exudation.
7. âŚPATHOPHYSIOLOGY
2.Cellular response is in the form of conjunctival
infiltration and exudation in the discharge of
eosinophils, plasma cells and mast cells
producing histamine and histamine-like
substances.
3.Conjunctival response is in the form of boggy
swelling of conjunctiva followed by increased
connective tissue formation and mild papillary
hyperplasia.
9. DIAGNOSIS
⢠Diagnosisis made from:
a. typical symptoms and signs
b. normal conjunctival flora and
c. presence of abundant eosinophils in the
discharge
10. VERNAL KERATOCONJUNCTIVITIS (VKC) OR
SPRING CATARRH
⢠It is a recurrent, bilateral, interstitial, self-
limiting, allergic inflammation of the
conjunctiva having a periodic seasonal
incidence.
⢠It is considered as a hypersensitivity reaction
to some exogenous allergens.
12. PREDISPOSING FACTORS
1.Age
⢠4-20 years
2.sex
⢠more common in boys than girls.
3.Season
⢠More common in summer.
⢠Recently, it is being labelled as 'Warm weather
conjunctivitis'
3. Climate.
⢠More prevalent in tropics, less in temperate zones and
almost non-existent in coldclimate.
13. PATHOPHYSIOLOGY
1.Conjunctival epithelium hyperplasia
2.Marked cellular infiltration in the Adenoid
layer
3. Proliferation of fibrous layer which later on
undergoes hyaline changes.
4. proliferation,increased permeability and
vasodilation of Conjunctival vessels.
14. Symptoms
⢠Marked burning and itching sensation
- Itching is more marked with palpebral form of
disease
⢠Mild photophobia
⢠Lacrimation,
⢠Stringy (ropy) discharge and heaviness of lids
15. SIGNS
Described in following three clinical forms:
1.Palpebral VKC - upper tarsus
⢠papillae - hard, flat topped arranged in a
'cobble-stone' or 'pavement stone', fashion
- In severe cases, 'giant papillae'.
⢠white ropy discharge
16. âŚSIGNS
2.Bulbar VKC
⢠Dusky red triangular congestion of bulbar
conjunctiva
⢠Gelatinous thickened accumulation of tissue
around the limbus
⢠Presence of discrete whitish raised dots along
the limbus (Tranta's spots)
3.Mixed VKC
It shows combined features of both palpebral and
bulbar forms
17. KERATOPATHY
It is due to corneal involvement in VKC. The
following are some of corneal lesions due to
VKC.
⢠Superior punctate epithelial keratitis
⢠Ulcerative vernal keratitis (shield ulceration)
⢠Vernal corneal plaques
⢠Subepithelial scarring
⢠Pseudogerontoxon
18. Atopic keratoconjunctivitis (AKC)
⢠Adult equivalent of vernal keratoconjunctivitis
and is often associated with atopic dermatitis.
Most of the patients are young atopic adults,
with male predominance.
19. Pathophysiology
⢠The underlying mechanism is thought to be a
combined type I and type IV hypersensitivity
response.
⢠AKC has a protracted course with
exacerbations and remissions. AKC tends to be
perennial and is often worse in the winter.
⢠Like vernal keratoconjunctivitis it tends to
become inactive when the patient reaches the
fifth decade.
21. Signs
⢠Lid margins are chronically inflamed with
rounded posterior borders.
⢠Tarsal conjunctiva has a milky appearance.
There are very fine papillae, hyperaemia and
scarring with shrinkage.
⢠Cornea may show punctate epithelial
keratitis, often more severe in lower half.
There may also occur corneal vascularization,
thinning and plaques.
22. Diagnosis
⢠Diagnosis is clinical but can be aided by raised
serum and tear IgE levels.
⢠Symptoms are similar to those of VKC, but are
frequently more severe and unremitting.
⢠Discharge is generally more watery than the
stringy mucoid discharge in VKC.
23. GIANT PAPILLARY CONJUNCTIVITIS (GPC)
⢠It is the inflammation of conjunctiva with
formation of very large sized papillae.
24. Etiology
⢠It is a localised allergic response to a physically
rough or deposited surface (contact lens,
prosthesis, left out nylon sutures). Probably it
is a sensitivity reaction to components of the
plastic leached out by the action of tears.
25. Pathophysiology
⢠GPC can occur secondary to a variety of
mechanical stimuli of the tarsal conjunctiva. It
is most frequently encountered with contact
lens (CL) wear, termed as when it is termed
contact lens-associated papillary conjunctivitis
(CLPC).
26. Signs and Symptoms
⢠Itching, stringy discharge and reduced
wearing time of contact lens.
⢠Signs
ďź Papillary hypertrophy (1 mm in diameter) of
the upper tarsal conjunctiva, similar to that
seen in palpebral form of VKC with
hyperaemia are the main sign.
ďźSubstantial CL protein deposits may be
present.
27. PHLYCTENULAR KERATOCONJUNCTIVITIS
⢠Phlyctenular keratoconjunctivitis is a
characteristic nodular affection occurring as
an allergic response of the conjunctival and
corneal epithelium to some endogenous
allergens to which they have become
sensitized.
28. Etiology
⢠It is believed to be a delayed hypersensitivity
(Type IV-cell mediated) response to
endogenous microbial proteins.
I. Causative allergens
ď Staphylococcus proteins
ď Other allergens may be proteins of Moraxella
Axenfeld bacillius and certain parasites
(worm infestation).
29. Pathophysiology
1. Stage of nodule formation : exudation and
infiltration of leucocytes into the deeper layers of
conjunctiva leading to a nodule formation.
2. Stage of ulceration. Later on necrosis occurs at
the apex of the nodule and an ulcer is formed.
3. Stage of granulation. Eventually floor of the ulcer
becomes covered by granulation tissue.
4. Stage of healing. Healing occurs usually with
minimal scarring.
30. Symptoms
⢠mild discomfort in the eye
⢠irritation and reflex watering.
⢠May be associated mucopurulent
conjunctivitis due to secondary bacterial
infection.
31. Signs.
⢠The phlyctenular conjunctivitis can present in three
forms.
1. Simple phylctenular conjunctivitis. It is characterised by
the presence of a typical pinkish white nodule
surrounded by hyperaemia on the bulbar conjunctiva,
usually near the limbus.
2. Necrotizing phlyctenular conjunctivitis is characterised
by the presence of a very large phlycten with necrosis
and ulceration leading to a severe pustular
conjunctivitis.
3. Miliary phlyctenular conjunctivitis: characterised by the
presence of multiple phlyctens which may be arranged
in the form of a ring around the limbus and may even
form a ring ulcer.
32. Differential diagnosis
⢠Phlyctenular conjunctivitis needs to be
differentiated from episcleritis, scleritis.
⢠Presence of one or more whitish raised
nodules on the bulbar conjunctiva near the
limbus, with hyperaemia usually of the
surrounding conjunctiva, are the diagnostic
features of the phlyctenular conjunctivitis.
34. Etiology
⢠It is in fact a delayed hypersensitivity (type IV)
response to prolonged contact with chemicals
and drugs. A few common topical ophthalmic
medications known to produce contact
dermoconjunctivitis are atropine, penicillin,
neomycin, soframycin and gentamycin.
35. Clinical features
⢠Cutaneous involvement is in the form of
weeping eczematous reaction, involving all
areas with which medication comes in
contact.
⢠Conjunctival response is in the form of
hyperaemia with a generalised papillary
response affecting the lower fornix and lower
palpebral conjunctiva more than the upper.
36. Diagnosis
⢠Typical clinical picture.
⢠Conjunctival cytology shows a lymphocytic
response with masses of eosinophils.
⢠Skin test to the causative allergen is positive in
most of the cases.
37. Managements startegies of allergic
conjunctivitis
⢠Avoiding allergen that trigger may be the best
solution.
⢠Definitive( pharmachologic) management
⢠Supportive management
38. 1.Ocular Decongestants
ďśMechanism of action
⢠This drugs are adrenergic agonist mainly alpha 1
receptor
⢠Local vasoconstrictor, temporarily reduces redness
and swallowen blood vessel
Example : Phenylephrine (action-selective alpha one
agonist).
39. ďśMechanism of action
⢠Blocks H1 receptors which control
.Itching
.Capillary dilation
.Increase in capillary permeability
⢠Thus providing symptomatic relief from
histamine activity.
Antihistamins
41. Mast cell stabilizer
ďśMechanism of action
-Mast cell stabilizers work by inhibiting mast cell
degranulation thereby reducing the release of inflammatory
substances.
- However, these agents do not eliminate inflammatory
mediators that have released prior to drug instillation.
Effective for VKC,AKC,GPC
Examples
â˘Cromolyn Sodium (Sodium cromoglycate) 4%
⢠Lodoxaminde 0.1%
⢠Pemirolast potassium 0.1% (Alamast)
⢠Nedocromil sodium 2% (Alocril)
42. Corticosteroids
ď Mechanism of action
-By inhibiting phospholipase A2 ,block the release of
arachidonic acid and its subsequent conversion to
eicosanoids.
-Inhibition of degranulation of mast cells, basophils and
neutrophils.
Examples
⢠Dexamethasone/0.1%/
⢠Fluorometholone 0.1%
⢠prednisolone acetate (0.125% and 1.0%)
N.B corticosteroids should be tapered, as our body has
corticoid hormones.
43. NSAIDs
ďśMechanism of action
⢠NSAIDs inhibit prostaglandin production from
arachidonic acid by blocking cyclooxygenase. which
results in vasoconstriction, decrease in vascular permeability.
⢠It penetrates the cornea & reaches concentrations
that reduces prostaglandin E levels in the aqueous
humor.
example : Ketorolac tromethamine 0.5%
Used for
Treatment
1. Elimination of allergens if possible.
2. Local palliative measures which provide immediate relief include:
i. Vasoconstrictors like adrenaline, ephedrine, and naphazoline.
ii. Sodium cromoglycate drops are very effective in preventing recurrent atopic cases.
iii. Steroid eye drops should be avoided. However, these may be prescribed for short duration in severe and non-responsive patients.
3. Systemic antihistaminic drugs are useful in acute cases with marked itching.
4. Desensitization has been tried without much rewarding results. However, a trial may be given in recurrent cases
Local therapy
1. Topical steroids. These are effective in all forms of spring catarrh. However, their use should be minimised, as they frequently cause steroid induced glaucoma. Therefore, monitoring of intraocular pressure is very important during steroid therapy. Frequent instillation (4 hourly) to start with (2 days) should be followed by maintenance therapy for 3-4 times a day for 2 weeks. Commonly used steroid solutions are of fluorometholone medrysone, betamethasone or dexamethasone. Medrysone and fluorometholone are safest of all these.
2. Mast cell stabilizers such as sodium cromoglycate (2%) drops 4-5 times a day are quite effective in controlling VKC, especially atopic cases. It is mast cell stabilizer. Azelastine eye drops are also effective in controlling VKC.
3. Topical antihistaminics are also effective.
4. Acetyl cysteine (0.5%) used topically has mucolytic properties and is useful in the treatment of early plaque formation.
5. Topical cyclosporine (1%) drops have been recently reported to be effective in severe unresponsive cases
Treatment is often frustrating. Treat facial eczema and lid margin disease
Sodium cromoglycate drops, steroids and tear supplements may be helpful for conjunctival lesions.
The risk is increased by the build-up of proteinaceous deposits and cellular debris on the contact lens surface. Ocular prostheses (Fig. 5.18), exposed sutures and scleral buckles, corneal surface irregularity and filtering blebs can all be responsible.
Treatment
1. The offending cause should be removed. After discontinuation of contact lens or artificial eye or removal of nylon sutures, the papillae resolve over a period of one month.
2. Disodium cromoglycate is known to relieve the symptoms and enhance the rate of resolution.
3. Steroids are not of much use in this condition
I. Causative allergens
Tuberculous proteins were considered, previously, as the most common cause.
2. Staphylococcus proteins are now thought to account for most of the cases.
3. Other allergens may be proteins of Moraxella Axenfeld bacillius and certain parasites (worm infestation).
Pathology 1. Stage of nodule formation. In this stage there occurs exudation and infiltration of leucocytes into the deeper layers of conjunctiva leading to a nodule formation. The central cells are polymorphonuclear and peripheral cells are lymphocytes. The neighbouring blood vessels dilate and their endothelium proliferates. 2. Stage of ulceration. Later on necrosis occurs at the apex of the nodule and an ulcer is formed. Leucocytic infiltration increases with plasma cells and mast cells. 3. Stage of granulation. Eventually floor of the ulcer becomes covered by granulation tissue. 4. Stage of healing. Healing occurs usually with minimal scarring.
The phlyctenular conjunctivitis can present in three forms.
1. Simple phylctenular conjunctivitis. It is the most commonly seen variety. It is characterised by the presence of a typical pinkish white nodule surrounded by hyperaemia on the bulbar conjunctiva, usually near the limbus. Most of the times there is solitary nodule but at times there may be two nodules In a few days the nodule ulcerates at apex which later on gets epithelised. Rest of the conjunctiva is normal. 2. Necrotizing phlyctenular conjunctivitis is characterised by the presence of a very large phlycten with necrosis and ulceration leading to a severe pustular conjunctivitis. 3. Miliary phlyctenular conjunctivitis is characterised by the presence of multiple phlyctens which may be arranged haphazardly or in the form of a ring around the limbus and may even form a ring ulcer.
Management
It includes treatment of phlyctenular conjunctivitis by local therapy, investigations and specific therapy aimed at eliminating the causative allergen and general measures to improve the health of the child.
Local therapy.
i. Topical steroids, in the form of eye drops or ointment (dexamethasone or betamethasone) produce dramatic effect in phlyctenular keratoconjunctivitis.
ii. Antibiotic drops and ointment should be added to take care of the associated secondary infection (mucopurulent conjunctivitis).
iii. Atropine (1%) eye ointment should be applied once daily when cornea is involved.
There by blocking release of arachidonic acid and its subsequent conversion to eicosanoids.
-Inhibition of degranulation of mast cells, basophils and neutrophils
-This drugs are lipophilic which can easily cross cell membrane and gain access to cytoplasm.